Millennium Management’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $605K | Buy |
1,944,904
+1,835,806
| +1,683% | +$571K | ﹤0.01% | 3270 |
|
2025
Q1 | $53.3K | Sell |
109,098
-1,220,051
| -92% | -$596K | ﹤0.01% | 3820 |
|
2024
Q4 | $1.14M | Buy |
1,329,149
+1,051,779
| +379% | +$901K | ﹤0.01% | 2820 |
|
2024
Q3 | $2.36M | Buy |
277,370
+166,462
| +150% | +$1.41M | ﹤0.01% | 2452 |
|
2024
Q2 | $518K | Sell |
110,908
-815,517
| -88% | -$3.81M | ﹤0.01% | 3190 |
|
2024
Q1 | $6.3M | Buy |
926,425
+326,387
| +54% | +$2.22M | ﹤0.01% | 1820 |
|
2023
Q4 | $2.01M | Buy |
+600,038
| New | +$2.01M | ﹤0.01% | 2454 |
|
2023
Q3 | – | Sell |
-47,760
| Closed | -$61.1K | – | 4145 |
|
2023
Q2 | $61.1K | Sell |
47,760
-134,066
| -74% | -$172K | ﹤0.01% | 3939 |
|
2023
Q1 | $147K | Buy |
181,826
+119,883
| +194% | +$96.9K | ﹤0.01% | 3954 |
|
2022
Q4 | $47K | Sell |
61,943
-37,538
| -38% | -$28.5K | ﹤0.01% | 4457 |
|
2022
Q3 | $93K | Sell |
99,481
-261,333
| -72% | -$244K | ﹤0.01% | 4715 |
|
2022
Q2 | $342K | Buy |
360,814
+252,718
| +234% | +$240K | ﹤0.01% | 4146 |
|
2022
Q1 | $228K | Buy |
108,096
+37,735
| +54% | +$79.6K | ﹤0.01% | 4597 |
|
2021
Q4 | $630K | Buy |
70,361
+58,428
| +490% | +$523K | ﹤0.01% | 3836 |
|
2021
Q3 | $198K | Buy |
+11,933
| New | +$198K | ﹤0.01% | 4732 |
|
2021
Q2 | – | Sell |
-19,334
| Closed | -$363K | – | 4962 |
|
2021
Q1 | $363K | Sell |
19,334
-63,959
| -77% | -$1.2M | ﹤0.01% | 3835 |
|
2020
Q4 | $1.83M | Buy |
83,293
+50,628
| +155% | +$1.11M | ﹤0.01% | 2563 |
|
2020
Q3 | $678 | Buy |
32,665
+18,904
| +137% | +$392 | ﹤0.01% | 2704 |
|
2020
Q2 | $497K | Sell |
13,761
-75,563
| -85% | -$2.73M | ﹤0.01% | 2740 |
|
2020
Q1 | $2.92M | Buy |
+89,324
| New | +$2.92M | 0.01% | 1409 |
|
2019
Q4 | – | Sell |
-26,290
| Closed | -$288K | – | 3443 |
|
2019
Q3 | $288K | Sell |
26,290
-29,945
| -53% | -$328K | ﹤0.01% | 2981 |
|
2019
Q2 | $463K | Buy |
+56,235
| New | +$463K | ﹤0.01% | 2787 |
|